Mechanisms of treatment-related symptoms in cancer patients

por Cleeland, Charles S.
Publicado 2013

An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D

por Feng, Yan, Herdman, Mike, van Nooten, Floortje, Cleeland, Charles, Parkin, David, Ikeda, Shunya, Igarashi, Ataru, Devlin, Nancy J.
Publicado 2017

The Treatment-induced Neuropathy Assessment Scale (TNAS): a psychometric update following qualitative enrichment

por Mendoza, Tito R., Williams, Loretta A., Shi, Qiuling, Wang, Xin Shelley, Bamidele, Oluwatosin, Woodruff, Jeanie F., Cleeland, Charles S.
Publicado 2020

Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting

por Kamal, Mona, Navai, Neema, Bree, Kelly K., Williams, Loretta A., Cleeland, Charles S., Shen, Shu-En, Wang, Xin Shelley
Publicado 2022

Unnecessary Removal of Central Venous Catheters in Cancer Patients with Bloodstream Infections: Impact on Symptom Burden

por Chaftari, Anne-Marie, Raad, Sammy, Hachem, Ray Y, Shah, Pankil, Jiang, Ying, Natividad, Elizabeth, Cleeland, Charles, Rosenblatt, Joel, Raad, Issam
Publicado 2017

Utility of Patient-Reported Symptom and Functional Outcomes to Indicate Recovery after First 90 Days of Radical Cystectomy: A Longitudinal Study

por Wang, Xin Shelley, Bree, Kelly K., Navai, Neema, Kamal, Mona, Shen, Shu-En, Letona, Elizabeth, Cleeland, Charles S., Shi, Qiuling, Gottumukkala, Vijaya
Publicado 2023

The Anti-Diabetic Drug Metformin Protects against Chemotherapy-Induced Peripheral Neuropathy in a Mouse Model

por Mao-Ying, Qi-Liang, Kavelaars, Annemieke, Krukowski, Karen, Huo, Xiao-Jiao, Zhou, Wenjun, Price, Theodore J., Cleeland, Charles, Heijnen, Cobi J.
Publicado 2014

Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium Guidance

por Banerjee, Anjan K., Okun, Sally, Edwards, I. Ralph, Wicks, Paul, Smith, Meredith Y., Mayall, Stephen J., Flamion, Bruno, Cleeland, Charles, Basch, Ethan
Publicado 2013

Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM)

por Mendoza, Tito R., Williams, Loretta A., Keating, Karen N., Siegel, Jonathan, Elbi, Cem, Nowak, Anna K., Hassan, Raffit, Cuffel, Brian, Cleeland, Charles S.
Publicado 2019

Burden of symptoms associated with development of metastatic bone disease in patients with breast cancer

por Cleeland, Charles, von Moos, Roger, Walker, Mark S., Wang, Yuanyuan, Gao, Jianqing, Chavez-MacGregor, Mariana, Liede, Alexander, Arellano, Jorge, Balakumaran, Arun, Qian, Yi
Publicado 2016

Shortness of Breath on Day 1 After Surgery Alerting the Presence of Early Respiratory Complications After Surgery in Lung Cancer Patients

por Yu, Qingsong, Yu, Hongfan, Xu, Wei, Pu, Yang, Nie, Yuxian, Dai, Wei, Wei, Xing, Wang, Xin Shelley, Cleeland, Charles S, Li, Qiang, Shi, Qiuling
Publicado 2022

Validation of the M. D. Anderson Symptom Inventory multiple myeloma module

por Jones, Desiree, Vichaya, Elisabeth G, Wang, Xin Shelley, Williams, Loretta A, Shah, Nina D, Thomas, Sheeba K, Johnson, Valen E, Champlin, Richard E, Cleeland, Charles S, Mendoza, Tito R
Publicado 2013

Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases

por von Moos, Roger, Body, Jean-Jacques, Egerdie, Blair, Stopeck, Alison, Brown, Janet, Fallowfield, Lesley, Patrick, Donald L., Cleeland, Charles, Damyanov, Danail, Palazzo, Felipe Salvador, Marx, Gavin, Zhou, Ying, Braun, Ada, Balakumaran, Arun, Qian, Yi
Publicado 2015

Cancer-Related Internet Use and Its Association With Patient Decision Making and Trust in Physicians Among Patients in an Early Drug Development Clinic: A Questionnaire-Based Cross...

por George, Goldy C, Iwuanyanwu, Eucharia C, Buford, Adrianna S, Piha-Paul, Sarina A, Subbiah, Vivek, Fu, Siqing, Karp, Daniel D, Pant, Shubham, Hinojosa, Christina O, Hess, Kenneth R, Cleeland, Charles S, Bernstam, Elmer V, Meric-Bernstam, Funda, Hong, David S
Publicado 2019

A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second‐ and third‐generation tyrosine kinase inhibitors...

por Zulbaran‐Rojas, Alejandro, Lin, Huei‐Kan, Shi, Qiuling, Williams, Loretta A., George, Binsah, Garcia‐Manero, Guillermo, Jabbour, Elias, O’Brien, Susan, Ravandi, Farhad, Wierda, William, Estrov, Zeev, Borthakur, Gautam, Kadia, Tapan, Cleeland, Charles, Cortes, Jorge E., Kantarjian, Hagop
Publicado 2018

Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID)

por Williams, Loretta A., Whisenant, Meagan S., Mendoza, Tito R., Peek, Angela E., Malveaux, Donna, Griffin, Donna K., Ponce, Darcy A., Granwehr, Bruno Palma, Sheshadri, Ajay, Hutcheson, Katherine A., Ali, Sara M., Peterson, Susan K., Heymach, John V., Cleeland, Charles S., Subbiah, Ishwaria M.
Publicado 2023

Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma

por Baljevic, Muhamed, Zaman, Shadia, Baladandayuthapani, Veerabhadran, Lin, Yan Heather, de Partovi, Claudia Morales, Berkova, Zuzana, Amini, Behrang, Thomas, Sheeba K., Shah, Jatin J., Weber, Donna M., Fu, Min, Cleeland, Charles S., Wang, Xin Shelley, Stellrecht, Christine M., Davis, Richard E., Gandhi, Varsha, Orlowski, Robert Z.
Publicado 2017

Ruxolitinib for symptom control in patients with Chronic Lymphocytic leukemia: A Phase II Trial

por Jain, Preetesh, Keating, Michael, Renner, Sarah, Cleeland, Charles, Xuelin, Huang, Gonzalez, Graciela Nogueras, Harris, David, Li, Ping, Liu, Zhiming, Veletic, Ivo, Rozovski, Uri, Jain, Nitin, Thompson, Phillip, Bose, Prithviraj, DiNardo, Courtney, Ferrajoli, Alessandra, O’Brien, Susan, Burger, Jan, Wierda, William, Verstovsek, Srdan, Kantarjian, Hagop, Estrov, Zeev
Publicado 2017

Software for Administering the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study

por Schoen, Martin W, Basch, Ethan, Hudson, Lori L, Chung, Arlene E, Mendoza, Tito R, Mitchell, Sandra A, St. Germain, Diane, Baumgartner, Paul, Sit, Laura, Rogak, Lauren J, Shouery, Marwan, Shalley, Eve, Reeve, Bryce B, Fawzy, Maria R, Bhavsar, Nrupen A, Cleeland, Charles, Schrag, Deborah, Dueck, Amylou C, Abernethy, Amy P
Publicado 2018

Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial

por Mendoza, Tito R., Hong, David S., Peterson, Christine B., Stephen, Bettzy, Dumbrava, Ecaterina, Pant, Shubbam, Tsimberidou, Apostolia Maria, Yap, Timothy Anthony, Sheshadri, Ajay, Altan, Mehmet, George, Goldy, Castillo, Lilibeth, Rodriguez, Enedelia, Gong, Jing, Subbiah, Vivek, Janku, Filip, Fu, Siqing, Piha-Paul, Sarina A., Ahnert, Jordi Rodon, Karp, Daniel D., Cleeland, Charles, Meric-Bernstam, Funda, Naing, Aung
Publicado 2022